Sign in →

Browse by Name

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #
 

Mayo Clinic Laboratories

Test Code E2 Estradiol (E2)

Laboratory Code

LAB523

Specimen Requirements

Specimen Type: Serum
Container/Tube: Gold Top (SSTII) 
Volume: 5.0 mL
Minimum Volume: 0.5 mL serum
Collection Instructions: Allow specimen to clot for 30 mins and centrifuge within 2 hrs.

Specimen Stability

Specimen Type Serum
Ambient 24 hours
Refrigerate 7 days
Frozen 6 months

Methodology

Chemiluminescent Immunoassay

Days and Times Performed

24 hrs, TAT 1 day

Specimen Condition

Gross Haemolysis Alert/Reject
Icterus OK
Gross Lipaemia Alert/Reject
Others Not applicable

Reference Interval

Age Female
15 days – < 1 yr ≤ 92 pmol/L
9 – 10 yrs  ≤ 176 pmol/L
11 – < 12 yrs  ≤ 345 pmol/L
12 – 13 yrs ≤ 631 pmol/L
14 – 18 yrs ≤ 936 pmol/L

 

Age Male
15 days – < 1 yr ≤ 92 pmol/L
11 – 12 yrs ≤ 95 pmol/L
13 – 14 yrs ≤ 102 pmol/L
15 – 18 yrs ≤ 142 pmol/L
≥ 19 yrs ≤ 191 pmol/L

 

Normal Menstruating Females: 
Follicular Phase: ≤ 921 pmol/L 
Mid-Cycle Phase: 139 – 2382 pmol/L 
Luteal Phase: ≤ 1145 pmol/L 
Postmenopausal Females not on HRT: ≤ 103 pmol/L 
Postmenopausal Females on HRT: ≤ 528 pmol/L 
HRT: Hormone Replacement Therapy

 

Female 
Tanner Stage I: Not available 
Tanner Stage II: ≤ 96 pmol/L 
Tanner Stage III: ≤ 317 pmol/L 
Tanner Stage IV: ≤ 517 pmol/L 
Tanner Stage V: ≤ 762 pmol/L

 

Male 
Tanner Stage I: Not available 
Tanner Stage II: Not available 
Tanner Stage III: Not available 
Tanner Stage IV: ≤ 128 pmol/L 
Tanner Stage V: ≤ 126 pmol/L 

 

This Estradiol assay should not be used to assess Estradiol levels for patients undergoing Fulvestrant or Mifepristone treatment.

 

There is potential for cross reactivity with medications which inhibit tumour cell proliferation (e.g. CDK 4/6 inhibitors) and medications that activate or interfere with production of steroid hormones (e.g. Aromatase inhibitors).

 

In such cases, an alternate method such as mass spectrometry method may be used.

Testing Laboratory

National University Hospital

Clinical Chemistry, 67724346

Useful For

Female: Assessment of hypothalamic-pituitary ovarian axis.

Male: Investigation of unexplained gynaecomastia.

Service Code

31666

LOINC Code Information

83097-6

Update

Last updated 11/03/2025